2m 2m 2m 2m 2m 2m 2m
RELAY THERAPETCS (RLAY)
NASDAQ
$18.34-$0.07 (-0.38%)
Price as of Oct 22, 2026 7:30 PM EDT- $4.0BMarket Cap
- 184.10%1-Year Change
- BiotechnologyIndustry
RELAY THERAPETCS (RLAY)
$18.34-$0.07 (-0.38%)
RLAY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.41 | ||
Change | -$0.04 (-0.22%) | ||
Open | $18.61 | ||
High | $19.03 | ||
Low | $18.19 | ||
Previous Close | $18.45 | ||
Volume | 1,598,194 | ||
30-Day Average Volume | 2,811,074 | ||
1-Week Change | 7.91% | ||
1-Month Change | 1.21% | ||
1-Year Change | 184.10% | ||
3-Year Change | 171.94% | ||
5-Year Change | -41.09% | ||
Fundamentals | |||
Shares Outstanding | 219.1M | ||
Total Assets | $967.5M | ||
Market Cap | $4.0B | ||
Enterprise Value | $3.9B | ||
Period: QTR TTM FY | |||
Revenue | $350,000.00 | ||
Net Income | -$83.7M | ||
Free Cash Flow | -$53.7M | ||
EBIT | -$83.7M | ||
EBITDA | -$83.3M | ||
Net Working Capital | $877.3M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | -47 | ||
Enterprise Value/Revenue | 11,181 | ||
P/B | 5 | ||
P/E | -45 | ||
PEG | N/A | ||
Price/Free Cash Flow | -75 | ||
Price/Operating Cash Flow | -75 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue